Home / Health / Seniors Flock to New Medicare Weight Loss Drug Program
Seniors Flock to New Medicare Weight Loss Drug Program
1 Sep
Summary
- 600,000 seniors enrolled in a new federal program for weight loss drugs.
- The Medicare Bridge program offers obesity medications for $50 monthly.
- Millions of older Americans now qualify for this subsidized treatment.
A new federal initiative, the Medicare Bridge program, has seen remarkable uptake among seniors in its initial two months. As of August 31, 2026, an impressive 600,000 seniors have enrolled, seeking access to highly sought-after GLP-1 weight loss medications.
The program, which commenced in July, dramatically lowers the cost of these obesity treatments. Millions of older Americans now qualify to receive these medications for an affordable monthly price of just $50.
This expansion is designed to make crucial weight loss therapies more accessible to a population group that could greatly benefit from them. The significant enrollment numbers indicate a strong demand for such subsidized healthcare options.
